NEU 0.98% $19.50 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-191

  1. 2,348 Posts.
    lightbulb Created with Sketch. 730
    Yes it's not as straightforward as 50% or 90%. At 50% you basically have control as you can pass ordinary resolutions. At 75% you can pass special resolutions. As long as you still meet your fiduciary duty in the process this could see your asset sold to the predator/majority shareholder or similar. I would still expect a revised uplifted offer would go to minority holders if less than 90% take initial offer but definitely no guarantee of that.
    Last edited by nashezz: 29/04/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.50
Change
0.190(0.98%)
Mkt cap ! $2.490B
Open High Low Value Volume
$19.39 $19.98 $19.38 $7.285M 370.6K

Buyers (Bids)

No. Vol. Price($)
11 7318 $19.50
 

Sellers (Offers)

Price($) Vol. No.
$19.52 593 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$19.55
  Change
0.190 ( 0.83 %)
Open High Low Volume
$19.41 $19.97 $19.39 83274
Last updated 15.59pm 14/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.